IP Library › Granted Patent US 8,920,442
Granted Patent B2
US 8,920,442 · App. 11/508,662 · Granted Dec 30, 2014

Vascular opening edge eversion methods and apparatuses

Inventors: Wilmer L. Sibbitt, Jr. (Albuquerque, NM); Randy R. Sibbitt (Helena, MT)
Assignee: Abbott Vascular Inc.
A61B17/0057A61B2017/00349A61B2017/00668A61B2017/00637A61B2017/00663A61B2017/00862A61B2017/00004A61B2017/00672A61B17/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,920,442
App. No.
11/508,662
Granted
Dec 30, 2014
Kind
B2
Abstract

Tissue eversion apparatuses and methods suitable for use, as examples, with vascular closure devices. The tissue eversion apparatuses comprise a tissue engaging element, disposed within a delivery sheath. The delivery sheath protects the tissue engaging element and the surrounding tissue during use. The tissue engaging element can extend from the sheath and engage the tissue near an aperture in a tissue wall. Motion of the tissue engaging element away from the tissue can urge the tissue wall near the aperture to evert from the tissue wall, allowing, as examples, aperture closure apparatuses and methods to be conveniently employed.

Claims (23)

1. A tissue eversion device, comprising:

a) a delivery sheath having a distal end;

b) a tissue engaging element extending from a proximal end to the distal end of the delivery sheath, the tissue engaging element having a plurality of elongated members extending distally from the proximal end of the delivery sheath each having a tissue penetrating feature, the tissue engaging element has a first configuration wherein it is contained within the delivery sheath and a second configuration wherein each of the tissue penetrating feature extends distally beyond the distal end of an outer surface of the delivery sheath, wherein in the second configuration an intermediate portion of each elongate member extends distally from the distal end of the delivery sheath towards a longitudinal midline of the delivery sheath with an end portion of the intermediate portion being closer to the longitudinal midline than an end portion of the elongate member adjacent the distal end of the delivery sheath, and a curved end portion, extending from the end portion of the intermediate portion of each elongate member, is curled outwardly from the intermediate portion and then towards the longitudinal midline of the delivery sheath to terminate at a location spaced apart from the intermediate portion and form an open curved portion.

2. A tissue eversion device as in claim 1 , wherein each elongated member has an end adapted to engage tissue, wherein the elongated members reside within the delivery sheath substantially parallel to an axis of the delivery sheath when in the first configuration, and wherein the elongated members curve away from the axis when in the second configuration.

3. A tissue eversion device as in claim 2 , wherein the elongated members have sharpened ends.

4. A tissue eversion device as in claim 1 , wherein the tissue engaging element comprises metal.

5. A tissue eversion device as in claim 1 , wherein the tissue engaging element comprises bioabsorbable polymer, bioabsorbable compound, non-absorbable alloy, non-absorbable compound, stainless steel, MP35, Nitinol, Nickel-Titanium ally, Kevlar, nylon polyester acrylic, gold, platinum, tantalum, niobium, molybdenum, rhodium, palladium silver, hafnium, tungsten, iridium, artificial muscle, shape memory alloy, or a combination thereof.

6. A tissue eversion device as in claim 1 , wherein the tissue engaging element comprises a fixture adapted to attach to a retracting element.

7. A tissue eversion device as in claim 1 , wherein the tissue engaging element is moveable relative to the delivery sheath along an axis of the delivery sheath, and wherein motion of the tissue engaging element along the axis past the end of the delivery sheath allows the tissue engaging element to attain the second configuration, and wherein motion of the tissue engaging element into the end of the delivery sheath causes the tissue engaging element to attain the first configuration.

8. A tissue eversion device as in claim 1 , wherein the elongated members flex or curl outwards relative to the delivery sheath to attain the second configuration.

9. A tissue eversion device as in claim 1 , wherein the tissue engaging element can be actuated to attain the second configuration by action of a plunger and flanges mounted with the device.

10. A tissue eversion device as in claim 1 , wherein the elongated members are movably mounted within individual lumens within the delivery sheath.

11. A tissue eversion device, comprising:

a) a delivery sheath having a distal end;

b) a plurality of elongated members extending distally from a proximal end of the delivery sheath to the distal end and each having a tissue penetrating feature, each elongated member of the plurality of elongated members has a first configuration wherein it is contained within the delivery sheath and a second configuration where the elongated member extends distally beyond the distal end of the outer surface of the delivery sheath, wherein in the second configuration an intermediate portion of each elongate member extends distally from the distal end of the delivery sheath towards a longitudinal midline of the delivery sheath with an end portion of the intermediate portion being closer to the longitudinal midline than an end portion of the elongate member adjacent the distal end of the delivery sheath, and a curved end portion of the intermediate portion of each elongate member is curled outwardly from and then towards the longitudinal midline of the delivery sheath to terminate at a location spaced apart from the intermediate portion and form an open curved portion, the intermediate portion being proximal to the curved end portion curling outwardly from the longitudinal midline of the delivery sheath.

12. A tissue eversion device as in claim 11 , wherein the tissue penetrating feature is a sharp hook-like portion, a textured portion, hooks, or teeth.

13. A tissue eversion device as in claim 12 , wherein the elongated members reside within the delivery sheath substantially parallel to an axis of the delivery sheath when in the first configuration and wherein the elongated members curve away from the axis when in the second configuration.

14. A tissue eversion device as in claim 11 , wherein the elongated members comprise metal.

15. A tissue eversion device as in claim 11 , wherein the elongated members comprise bioabsorbable polymer, bioabsorbable compound, non-absorbable alloy, non-absorbable compound, stainless steel, MP35, Nitinol, Nickel-Titanium ally, Kevlar, nylon polyester acrylic, gold, platinum, tantalum, niobium, molybdenum, rhodium, palladium silver, hafnium, tungsten, iridium, artificial muscle, shape memory alloy, or a combination thereof.

16. A tissue eversion device as in claim 11 , wherein the elongated members are moveable relative to the delivery sheath along an axis of the delivery sheath, and wherein motion of the elongated members along the axis past the end of the delivery sheath allows the elongated members to attain the second configuration, and wherein motion of the elongated members into the end of the delivery sheath causes the elongated members to attain the first configuration.

17. A tissue eversion device as in claim 11 , wherein the first configuration is a high energy retracted state and the second configuration is a low energy extended state.

18. A tissue eversion device as in claim 11 , comprising two lumens disposed within the delivery sheath, each lumen configured to receive one of the plurality of elongated members.

19. A tissue eversion device as in claim 11 , wherein the plurality of elongated members can be actuated to attain the second configuration by action of a plunger and flanges mounted with the device.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2009
From: AVASCA MEDICAL, INC.
To: ABBOTT VASCULAR INC.
Reel/Frame 022525/0443 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2007
From: SIBBITT, WILMER L, JR.; SIBBITT, RANDY R
To: AVASCA MEDICAL INC.
Reel/Frame 020087/0533 →
Continuity (4)
Continuation In Part 11316775 · Dec 23, 2005
Provisional Application 60726985 · Oct 14, 2005
Provisional Application 60711279 · Aug 24, 2005
Related Publication 20070049968A1 · Mar 1, 2007